{"id":38446,"date":"2025-11-15T09:00:00","date_gmt":"2025-11-15T08:00:00","guid":{"rendered":"https:\/\/www.etap-lab.com\/?post_type=ressource&#038;p=38446"},"modified":"2026-10-16T15:55:33","modified_gmt":"2026-10-16T13:55:33","slug":"poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery","status":"publish","type":"ressource","link":"https:\/\/www.etap-lab.com\/en\/ressource\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\/","title":{"rendered":"Poster: High-Throughput Brain-on-Chip Platform for Accelerating Neurodegenerative Drug Discovery"},"content":{"rendered":"\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-7387b849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-7387b849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Consult the scientific poster dealing with <strong>High-Throughput Brain-on-Chip Platform for Accelerating Neurodegenerative Drug Discovery<\/strong>, presented by Nicolas Violle for BRAINXPLORE team at the Neuroscience congress (SfN) in San Diego (United-States, November 2025). Neurodegenerative diseases such as Alzheimer&#8217;s disease are characterized by early synaptic dysfunction and neurite degeneration, long before the onset of irreversible neuronal loss. To better understand these early pathological mechanisms and improve the predictability of preclinical research, ETAP-LAB has developed <strong>a high-throughput Brain-on-Chip platform combining advanced microfluidic technologies, human iPSC-derived neurons, and high-content imaging.<\/strong> This innovative approach enables precise investigation of neurotoxic processes, identification of early therapeutic targets, and accelerated screening of novel drug candidates for Alzheimer&#8217;s disease and related neurodegenerative disorders. The poster presents the potential to uncover early-stage disease processes and accelerate the discovery of novel therapeutic candidates for AD and related disorders.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><em>Related articles:<\/em><\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.etap-lab.com\/en\/ressource\/technical-note-high-content-imaging-of-brain-on-chip-microfluidic-devices-using-preciscan-intelligent-acquisition\/\" data-type=\"ressource\" data-id=\"36371\">Technical Note: High-content imaging of brain-on-chip microfluidic devices using PreciScan intelligent acquisition<\/a><\/li>\n\n\n\n<li>Publication on <a href=\"https:\/\/www.etap-lab.com\/en\/ressource\/publication-on-functional-discrimination-of-csf-from-alzheimers-patients-in-a-brain-on-chip-platform\/\" data-type=\"ressource\" data-id=\"36379\">Functional discrimination of CSF from Alzheimer\u2019s patients in a brain on chip platform<\/a><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vert-color\"><strong>Keywords<\/strong>: Alzheimer\u2019s disease; synapses; oligomers; high-throughput; Brain-on-Chip.<\/mark><\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-7387b849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>Authors<\/strong>: Nicolas VIOLLE<sup>1<\/sup> , Valentin TALLANDIER<sup>1<\/sup>, L\u00e9ane Dier<sup>1<\/sup>, Sonia KRIDI<sup>1<\/sup>, Ahmad ALLOUCHE<sup>1<\/sup>, Julie COLIN<sup>1<\/sup><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Affiliated<\/strong>: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>1. ETAP-LAB, 54500, Vand\u0153uvre-l\u00e8s-Nancy, France<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-7387b849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\">\n<figure class=\"wp-block-image alignright size-medium is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"212\" src=\"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2026\/10\/Capture-Poster-BrainOnChip-HCS-BRAINXPLORE-Neuroscience-SfN-2025-300x212.png\" alt=\"illustration-Poster-BrainOnChip-HCS-BRAINXPLORE-Neuroscience-SfN-2025\" class=\"wp-image-38447\" style=\"width:300px;height:auto\" srcset=\"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2026\/10\/Capture-Poster-BrainOnChip-HCS-BRAINXPLORE-Neuroscience-SfN-2025-300x212.png 300w, https:\/\/www.etap-lab.com\/wp-content\/uploads\/2026\/10\/Capture-Poster-BrainOnChip-HCS-BRAINXPLORE-Neuroscience-SfN-2025.png 512w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-primary\"><a class=\"wp-block-button__link wp-element-button\" href=\"mailto:marketing@etap-lab.com?subject=Poster%20Request%20-%20ETAP-LAB%20-BoC-Platform-SfN-2025%20&amp;body=Hello%2C%20%0ACan%20you%20send%20me%20the%20poster%20dealing%20with%20Bran-on-chip%20\/%20presented%20at%20SfN-2025.%20Thank%20you.%20\">Easy poster request<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-7387b849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vert-color\">Abstract:<\/mark><\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading has-m-font-size\">Background: Addressing Early Neurodegeneration and Translational Challenges in Alzheimer&#8217;s Disease<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Synaptic dysfunction and loss, followed by neurite degeneration are among the earliest and most critical events in neurodegenerative diseases (NDD) such as Alzheimer\u2019s disease (AD). These early pathological changes are strongly linked to cognitive decline and remain underexploited as therapeutic targets. Numerous drug candidates have failed in clinical trials due to late stage targeting and the poor translational value of current preclinical models. Therefore, there is a pressing need for predictive, high-throughput platforms that replicate early-stage neurodegeneration and support drug discovery.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-m-font-size\">Development of an Advanced Brain-on-Chip Platform for Alzheimer&#8217;s Disease Research<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">We developed Brain-on-Chip (BoC) systems combining standard 2D cultures exposed to disease-relevant neurotoxins: amyloid-beta oligomers (A\u03b2O) and tau oligomers (TauO) and <a href=\"https:\/\/www.etap-lab.com\/en\/cro-services\/neurology-cns\/in-vitro-models\/#subcat-201\">compartmentalized microfluidic devices to model the early stages of AD<\/a>. In addition to primary cortical neurons, we incorporated human induced pluripotent stem cell-derived neurons to enhance translational relevance. Here, we also report progress in developing high-throughput in vitro systems using a high-content imaging system and automated analyses.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-m-font-size\">Methods: Microfluidic Models, Human iPSC-Derived Neurons, and High-Content Imaging<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">To investigate mechanisms of neurotoxicity, we labeled A\u03b2O to track their axonal uptake, intracellular transport, and nuclear entry.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-m-font-size\">Results: Amyloid-Beta and Tau Oligomers Drive Early Neurodegenerative Mechanisms<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Our findings demonstrate that:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vert-color\">A\u03b2O and TauO significantly impair axonal integrity and induce neurodegeneration;<\/mark><\/li>\n\n\n\n<li><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vert-color\">Compartmentalized microfluidic models enable targeted manipulation and analysis of synapses and axons, supporting more nuanced investigation of the early stages of AD;<\/mark><\/li>\n\n\n\n<li><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vert-color\">Axonal exposure to labeled A\u03b2O reveals their active axonal transport, with subsequent accumulation observed in the neuronal nucleus;<\/mark><\/li>\n\n\n\n<li><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vert-color\"><a href=\"https:\/\/www.etap-lab.com\/en\/cro-services\/our-platforms\/#brain-on-chip-platform\">High-content imaging methods<\/a> accelerate the investigation of early neurodegenerative mechanisms and the screening of drug candidates.<\/mark><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading has-m-font-size\">Understanding Synaptic and Axonal Vulnerabilities in Alzheimer&#8217;s Disease<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">These investigations aim to uncover critical steps in the pathogenic process, enhancing our ability to target early mechanisms of NDD progression and increasing the predictive power of BoC platforms for drug discovery. While 2D cultures confirmed synaptotoxicity and neurite degeneration, microfluidic devices revealed compartment-specific vulnerabilities by targeting neurotoxins to somatic, axonal, or synaptic regions.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-m-font-size\">Conclusion: Accelerating Neurodegenerative Drug Discovery with High-Throughput Brain-on-Chip Models<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In conclusion, the ability to isolate and study these regions independently provides a powerful tool to deepen our understanding of NDD. These high-throughput and physiologically relevant models have strong potential to uncover early-stage disease processes and accelerate the discovery of novel therapeutic candidates for AD and related disorders.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Consult the scientific poster dealing with High-Throughput Brain-on-Chip Platform for Accelerating Neurodegenerative Drug Discovery, presented by Nicolas Violle for BRAINXPLORE team at the Neuroscience congress (SfN) in San Diego (United-States, November 2025). Neurodegenerative diseases such as Alzheimer&rsquo;s disease are characterized by early synaptic dysfunction and neurite degeneration, long before the onset of irreversible neuronal loss. [&hellip;]<\/p>\n","protected":false},"featured_media":38150,"template":"","meta":{"_acf_changed":false},"categorie-de-ressource":[236],"marque-de-ressource":[240],"class_list":["post-38446","ressource","type-ressource","status-publish","has-post-thumbnail","hentry","categorie-de-ressource-posters","marque-de-ressource-brainxplore"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Poster: High-Throughput Brain-on-Chip Platform for Accelerating Neurodegenerative Drug Discovery - ETAP-LAB<\/title>\n<meta name=\"description\" content=\"Brain-on-Chip technology for Alzheimer&#039;s and neurodegenerative disease research, featuring microfluidics, iPSC neurons, and high-throughput screening.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.etap-lab.com\/en\/ressource\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Poster: High-Throughput Brain-on-Chip Platform for Accelerating Neurodegenerative Drug Discovery - ETAP-LAB\" \/>\n<meta property=\"og:description\" content=\"Brain-on-Chip technology for Alzheimer&#039;s and neurodegenerative disease research, featuring microfluidics, iPSC neurons, and high-throughput screening.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.etap-lab.com\/en\/ressource\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\/\" \/>\n<meta property=\"og:site_name\" content=\"ETAP-LAB\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-16T13:55:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2026\/05\/ETAP-Ressources-Poster-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2151\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/ressource\\\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\\\/\",\"url\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/ressource\\\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\\\/\",\"name\":\"Poster: High-Throughput Brain-on-Chip Platform for Accelerating Neurodegenerative Drug Discovery - ETAP-LAB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/ressource\\\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/ressource\\\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.etap-lab.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/ETAP-Ressources-Poster-1.jpg\",\"datePublished\":\"2025-11-15T08:00:00+00:00\",\"dateModified\":\"2026-10-16T13:55:33+00:00\",\"description\":\"Brain-on-Chip technology for Alzheimer's and neurodegenerative disease research, featuring microfluidics, iPSC neurons, and high-throughput screening.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/ressource\\\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/ressource\\\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/ressource\\\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.etap-lab.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/ETAP-Ressources-Poster-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.etap-lab.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/ETAP-Ressources-Poster-1.jpg\",\"width\":2151,\"height\":1200,\"caption\":\"Illustration for our scientific ressources and poster\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/ressource\\\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ressources\",\"item\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/ressources\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Posters\",\"item\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/categorie-de-ressource\\\/posters\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Poster: High-Throughput Brain-on-Chip Platform for Accelerating Neurodegenerative Drug Discovery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/\",\"name\":\"Etap Lab\",\"description\":\"CRO Services\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#organization\",\"name\":\"Etap Lab\",\"url\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.etap-lab.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/etap-lab-etap-lab-preclinical-cro-right-full-color-rgb-1920px-w-72ppi.png\",\"contentUrl\":\"https:\\\/\\\/www.etap-lab.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/etap-lab-etap-lab-preclinical-cro-right-full-color-rgb-1920px-w-72ppi.png\",\"width\":550,\"height\":550,\"caption\":\"Etap Lab\"},\"image\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/etap-lab\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Poster: High-Throughput Brain-on-Chip Platform for Accelerating Neurodegenerative Drug Discovery - ETAP-LAB","description":"Brain-on-Chip technology for Alzheimer's and neurodegenerative disease research, featuring microfluidics, iPSC neurons, and high-throughput screening.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.etap-lab.com\/en\/ressource\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\/","og_locale":"en_US","og_type":"article","og_title":"Poster: High-Throughput Brain-on-Chip Platform for Accelerating Neurodegenerative Drug Discovery - ETAP-LAB","og_description":"Brain-on-Chip technology for Alzheimer's and neurodegenerative disease research, featuring microfluidics, iPSC neurons, and high-throughput screening.","og_url":"https:\/\/www.etap-lab.com\/en\/ressource\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\/","og_site_name":"ETAP-LAB","article_modified_time":"2026-10-16T13:55:33+00:00","og_image":[{"width":2151,"height":1200,"url":"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2026\/05\/ETAP-Ressources-Poster-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.etap-lab.com\/en\/ressource\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\/","url":"https:\/\/www.etap-lab.com\/en\/ressource\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\/","name":"Poster: High-Throughput Brain-on-Chip Platform for Accelerating Neurodegenerative Drug Discovery - ETAP-LAB","isPartOf":{"@id":"https:\/\/www.etap-lab.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.etap-lab.com\/en\/ressource\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\/#primaryimage"},"image":{"@id":"https:\/\/www.etap-lab.com\/en\/ressource\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2026\/05\/ETAP-Ressources-Poster-1.jpg","datePublished":"2025-11-15T08:00:00+00:00","dateModified":"2026-10-16T13:55:33+00:00","description":"Brain-on-Chip technology for Alzheimer's and neurodegenerative disease research, featuring microfluidics, iPSC neurons, and high-throughput screening.","breadcrumb":{"@id":"https:\/\/www.etap-lab.com\/en\/ressource\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.etap-lab.com\/en\/ressource\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.etap-lab.com\/en\/ressource\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\/#primaryimage","url":"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2026\/05\/ETAP-Ressources-Poster-1.jpg","contentUrl":"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2026\/05\/ETAP-Ressources-Poster-1.jpg","width":2151,"height":1200,"caption":"Illustration for our scientific ressources and poster"},{"@type":"BreadcrumbList","@id":"https:\/\/www.etap-lab.com\/en\/ressource\/poster-high-throughput-brain-on-chip-platform-for-accelerating-neurodegenerative-drug-discovery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.etap-lab.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ressources","item":"https:\/\/www.etap-lab.com\/en\/ressources\/"},{"@type":"ListItem","position":3,"name":"Posters","item":"https:\/\/www.etap-lab.com\/en\/categorie-de-ressource\/posters\/"},{"@type":"ListItem","position":4,"name":"Poster: High-Throughput Brain-on-Chip Platform for Accelerating Neurodegenerative Drug Discovery"}]},{"@type":"WebSite","@id":"https:\/\/www.etap-lab.com\/en\/#website","url":"https:\/\/www.etap-lab.com\/en\/","name":"Etap Lab","description":"CRO Services","publisher":{"@id":"https:\/\/www.etap-lab.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.etap-lab.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.etap-lab.com\/en\/#organization","name":"Etap Lab","url":"https:\/\/www.etap-lab.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.etap-lab.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2026\/03\/etap-lab-etap-lab-preclinical-cro-right-full-color-rgb-1920px-w-72ppi.png","contentUrl":"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2026\/03\/etap-lab-etap-lab-preclinical-cro-right-full-color-rgb-1920px-w-72ppi.png","width":550,"height":550,"caption":"Etap Lab"},"image":{"@id":"https:\/\/www.etap-lab.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/etap-lab\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/ressource\/38446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/ressource"}],"about":[{"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/types\/ressource"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/media\/38150"}],"wp:attachment":[{"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/media?parent=38446"}],"wp:term":[{"taxonomy":"categorie-de-ressource","embeddable":true,"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/categorie-de-ressource?post=38446"},{"taxonomy":"marque-de-ressource","embeddable":true,"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/marque-de-ressource?post=38446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}